BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20107608)

  • 1. Evolutionary trajectories of beta-lactamase CTX-M-1 cluster enzymes: predicting antibiotic resistance.
    Novais A; Comas I; Baquero F; Cantón R; Coque TM; Moya A; González-Candelas F; Galán JC
    PLoS Pathog; 2010 Jan; 6(1):e1000735. PubMed ID: 20107608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational events in cefotaximase extended-spectrum beta-lactamases of the CTX-M-1 cluster involved in ceftazidime resistance.
    Novais A; Cantón R; Coque TM; Moya A; Baquero F; Galán JC
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2377-82. PubMed ID: 18443114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftazidime Is the Key Diversification and Selection Driver of VIM-Type Carbapenemases.
    Martínez-García L; González-Alba JM; Baquero F; Cantón R; Galán JC
    mBio; 2018 May; 9(3):. PubMed ID: 29739906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?
    Ripoll A; Baquero F; Novais A; Rodríguez-Domínguez MJ; Turrientes MC; Cantón R; Galán JC
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4530-6. PubMed ID: 21788458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the global stabilizing substitution A77V and its role in the evolution of CTX-M β-lactamases.
    Patel MP; Fryszczyn BG; Palzkill T
    Antimicrob Agents Chemother; 2015 Nov; 59(11):6741-8. PubMed ID: 26282414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism between substitutions in β-lactamase explains a path not taken in the evolution of bacterial drug resistance.
    Brown CA; Hu L; Sun Z; Patel MP; Singh S; Porter JR; Sankaran B; Prasad BVV; Bowman GR; Palzkill T
    J Biol Chem; 2020 May; 295(21):7376-7390. PubMed ID: 32299911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for the catalytic specificity of the CTX-M extended-spectrum β-lactamases.
    Adamski CJ; Cardenas AM; Brown NG; Horton LB; Sankaran B; Prasad BV; Gilbert HF; Palzkill T
    Biochemistry; 2015 Jan; 54(2):447-57. PubMed ID: 25489790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
    Jeong SH; Bae IK; Kwon SB; Lee JH; Song JS; Jung HI; Sung KH; Jang SJ; Lee SH
    J Appl Microbiol; 2005; 98(4):921-7. PubMed ID: 15752339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects of functionally distinct substitutions in β-lactamase variants shed light on the evolution of bacterial drug resistance.
    Patel MP; Hu L; Brown CA; Sun Z; Adamski CJ; Stojanoski V; Sankaran B; Prasad BVV; Palzkill T
    J Biol Chem; 2018 Nov; 293(46):17971-17984. PubMed ID: 30275013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aeromonas spp. simultaneously harbouring bla(CTX-M-15), bla(SHV-12), bla(PER-1) and bla(FOX-2), in wild-growing Mediterranean mussel (Mytilus galloprovincialis) from Adriatic Sea, Croatia.
    Maravić A; Skočibušić M; Samanić I; Fredotović Z; Cvjetan S; Jutronić M; Puizina J
    Int J Food Microbiol; 2013 Sep; 166(2):301-8. PubMed ID: 23973842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae.
    Soge OO; Queenan AM; Ojo KK; Adeniyi BA; Roberts MC
    J Antimicrob Chemother; 2006 Jan; 57(1):24-30. PubMed ID: 16319181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTX-M-137, a hybrid of CTX-M-14-like and CTX-M-15-like β-lactamases identified in an Escherichia coli clinical isolate.
    Tian GB; Huang YM; Fang ZL; Qing Y; Zhang XF; Huang X
    J Antimicrob Chemother; 2014 Aug; 69(8):2081-5. PubMed ID: 24777903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel ceftazidime-hydrolysing extended-spectrum beta-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop.
    Bae IK; Lee BH; Hwang HY; Jeong SH; Hong SG; Chang CL; Kwak HS; Kim HJ; Youn H
    J Antimicrob Chemother; 2006 Aug; 58(2):315-9. PubMed ID: 16785225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and structural insights into plasmid-mediated extended-spectrum β-lactamase activity of CTX-M and SHV variants among pathogenic Enterobacteriaceae infecting Indian patients.
    Dhara L; Tripathi A
    Int J Antimicrob Agents; 2014 Jun; 43(6):518-26. PubMed ID: 24794736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of extended spectrum beta lactamase and molecular detection of blaTEM, blaSHV and blaCTX-M genotypes among Gram negative bacilli isolates from pediatric patient population in Gaza strip.
    El Aila NA; Al Laham NA; Ayesh BM
    BMC Infect Dis; 2023 Feb; 23(1):99. PubMed ID: 36803466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquisition of extended-spectrum beta-lactamase producing Escherichia coli strains in male and female infants admitted to a neonatal intensive care unit: molecular epidemiology and analysis of risk factors.
    Shakil S; Akram M; Ali SM; Khan AU
    J Med Microbiol; 2010 Aug; 59(Pt 8):948-954. PubMed ID: 20430903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network models of TEM β-lactamase mutations coevolving under antibiotic selection show modular structure and anticipate evolutionary trajectories.
    Guthrie VB; Allen J; Camps M; Karchin R
    PLoS Comput Biol; 2011 Sep; 7(9):e1002184. PubMed ID: 21966264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive analysis of ceftazidime hydrolysis in CTX-M-type beta-lactamase family members with a mutational substitution at position 167.
    Kimura S; Ishii Y; Tateda K; Yamaguchi K
    Int J Antimicrob Agents; 2007 Mar; 29(3):326-31. PubMed ID: 17258896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftazidime-hydrolysing CTX-M-15 extended-spectrum beta-lactamase (ESBL) in Poland.
    Baraniak A; Fiett J; Hryniewicz W; Nordmann P; Gniadkowski M
    J Antimicrob Chemother; 2002 Sep; 50(3):393-6. PubMed ID: 12205064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.